Granite Investment Partners’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-11,743
| Closed | -$51K | – | 314 |
|
|
2019
Q4 | $51K | Sell |
11,743
-77,573
| -87% | -$337K | ﹤0.01% | 282 |
|
|
2019
Q3 | $351K | Hold |
89,316
| – | – | 0.02% | 292 |
|
|
2019
Q2 | $415K | Sell |
89,316
-78,373
| -47% | -$364K | 0.02% | 286 |
|
|
2019
Q1 | $702K | Buy |
167,689
+78,373
| +88% | +$328K | 0.04% | 276 |
|
|
2018
Q4 | $307K | Hold |
89,316
| – | – | 0.02% | 295 |
|
|
2018
Q3 | $383K | Hold |
89,316
| – | – | 0.02% | 265 |
|
|
2018
Q2 | $332K | Hold |
89,316
| – | – | 0.02% | 270 |
|
|
2018
Q1 | $375K | Sell |
89,316
-160,960
| -64% | -$676K | 0.03% | 243 |
|
|
2017
Q4 | $1.47M | Hold |
250,276
| – | – | 0.09% | 170 |
|
|
2017
Q3 | $1.08M | Buy |
250,276
+13,599
| +6% | +$58.5K | 0.07% | 204 |
|
|
2017
Q2 | $904K | Sell |
236,677
-11,537
| -5% | -$44.1K | 0.06% | 243 |
|
|
2017
Q1 | $667K | Sell |
248,214
-6,024
| -2% | -$16.2K | 0.05% | 266 |
|
|
2016
Q4 | $842K | Sell |
254,238
-26,812
| -10% | -$88.8K | 0.06% | 247 |
|
|
2016
Q3 | $837K | Buy |
281,050
+144,987
| +107% | +$432K | 0.06% | 255 |
|
|
2016
Q2 | $564K | Buy |
+136,063
| New | +$564K | 0.04% | 267 |
|